105 related articles for article (PubMed ID: 10100984)
1. Dormant tumor-suppressor pathways in tumors.
Weintraub SJ
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):541-2. PubMed ID: 10100984
[No Abstract] [Full Text] [Related]
2. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
Fujishita T; Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
[TBL] [Abstract][Full Text] [Related]
3. [The efficacy of p16, p53 and p21 genes on the proliferation of lung cancer cells in vitro].
Wen G; Li J; Zou G; Fan X; Rao W
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):169-72. PubMed ID: 11812373
[TBL] [Abstract][Full Text] [Related]
4. [Molecular abnormalities in lung cancer].
Shimizu S; Mitsudomi T
Nihon Rinsho; 2002 May; 60 Suppl 5():73-7. PubMed ID: 12101773
[No Abstract] [Full Text] [Related]
5. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
6. Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells.
Ravi RK; Thiagalingam A; Weber E; McMahon M; Nelkin BD; Mabry M
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):543-9. PubMed ID: 10100985
[TBL] [Abstract][Full Text] [Related]
7. [Molecular genetics of human pancreatic cancer].
Villanueva A; Capellá G; Mangues R; Farré A; Lluís F
Gastroenterol Hepatol; 1999 Nov; 22(9):444-50. PubMed ID: 10638042
[No Abstract] [Full Text] [Related]
8. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
[TBL] [Abstract][Full Text] [Related]
9. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
Grimison B; Langan TA; Sclafani RA
Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase inhibitors in human neoplasms.
Miller CW; Koeffler HP
Leukemia; 1997 Apr; 11 Suppl 3():370-1. PubMed ID: 9209393
[No Abstract] [Full Text] [Related]
11. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
Hatta Y; Koeffler HP
Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
[TBL] [Abstract][Full Text] [Related]
12. The gene expression index c-myc x E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells.
DeMuth JP; Jackson CM; Weaver DA; Crawford EL; Durzinsky DS; Durham SJ; Zaher A; Phillips ER; Khuder SA; Willey JC
Am J Respir Cell Mol Biol; 1998 Jul; 19(1):18-24. PubMed ID: 9651176
[TBL] [Abstract][Full Text] [Related]
13. [Mutations of several tumor suppressor genes in primary retinoblastoma].
Huang Q; Tao Y; Yandell DW
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):10-2. PubMed ID: 11776785
[TBL] [Abstract][Full Text] [Related]
14. [Expression of tumor suppressor genes p16, p21 and p53 in a pair of lung adenocarcinoma cell lines with different metastasis potentials: Anip973 and AGZY83-a].
Wang B; Yan C; Wu Y; Gao H; Wang Q; Jin Y; Huang C; Zhang G; Fu S; Li P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):128-31. PubMed ID: 11295133
[TBL] [Abstract][Full Text] [Related]
15. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.
Modestou M; Puig-Antich V; Korgaonkar C; Eapen A; Quelle DE
Cancer Res; 2001 Apr; 61(7):3145-50. PubMed ID: 11306500
[TBL] [Abstract][Full Text] [Related]
16. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
17. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
[TBL] [Abstract][Full Text] [Related]
18. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
[TBL] [Abstract][Full Text] [Related]
19. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T
Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]